Cognitive resilience to apolipoprotein E ε4: Contributing factors in black and white older adults

JAMA Neurology

Volumn 72, Issue 3, 2015, Pages 340-348

  Kaup, Allison R ^a,b   Nettiksimmons, Jasmine ^b   Harris, Tamara B ^c   Sink, Kaycee M ^d   Satterfield, Suzanne ^e   Metti, Andrea L ^f   Ayonayon, Hilsa N ^g   Yaffe, Kristine ^a,b,g  

^a SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NATIONAL INSTITUTE ON AGING   (United States)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^f UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E4;

AGED; AGING; ARTICLE; BLACK PERSON; CAUCASIAN; CEREBROVASCULAR ACCIDENT; COGNITION; COGNITIVE RESILIENCE; COHORT ANALYSIS; COMMUNITY LIVING; COMORBIDITY; COPING BEHAVIOR; DEPRESSION; DIABETES MELLITUS; EDUCATIONAL STATUS; GENETIC RISK; GENOTYPE; HEALTH STATUS; HEART INFARCTION; HETEROZYGOTE; HUMAN; HYPERTENSION; INCOME; INTERVENTION STUDY; MINI MENTAL STATE EXAMINATION; OBESITY; PRIORITY JOURNAL; RISK FACTOR; SCORING SYSTEM; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SLEEP TIME; SPEECH INTELLIGIBILITY; VERY ELDERLY; FEMALE; FOLLOW UP; GENETICS; MALE; NEUROPSYCHOLOGICAL TEST; PHYSIOLOGY; PROSPECTIVE STUDY; PSYCHOLOGY; RISK REDUCTION; SOCIOECONOMICS;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; AGED, 80 AND OVER; AGING; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; COGNITION; COHORT STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; PROSPECTIVE STUDIES; RISK REDUCTION BEHAVIOR; SOCIOECONOMIC FACTORS;

EID: 84926283430     PISSN: 21686149     EISSN: 21686157     Source Type: Journal    
DOI: 10.1001/jamaneurol.2014.3978     Document Type: Article

References (38)

1. Slooter AJ, Cruts M, Kalmijn S, et al. Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam Study. Arch Neurol. 1998;55(7):964-968.
2. Rubinsztein DC, Easton DF. Apolipoprotein E genetic variation and Alzheimer's disease: a meta-analysis. Dement Geriatr Cogn Disord. 1999;10(3):199-209.
3. Schiepers OJG, Harris SE, Gow AJ, et al. APOE ε4 status predicts age-related cognitive decline in the ninth decade: longitudinal follow-up of the Lothian Birth Cohort 1921. Mol Psychiatry. 2012;17(3):315-324.
4. Corbo R, Scacchi R. Apolipoprotein E (APOE) allele distribution in the world: is APOE∗4 a "thrifty" allele? Ann Hum Genet. 1999;63(4):301-310.
5. Borenstein AR, Mortimer JA, Wu Y, et al. Apolipoprotein E and cognition in community-based samples of African Americans and Caucasians. Ethn Dis. 2006;16(1):9-15.
6. Farrer LA, Cupples LA, Haines JL, et al; APOE and Alzheimer Disease Meta Analysis Consortium. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: a meta-analysis. JAMA. 1997;278(16):1349-1356.
7. Fillenbaum GG, Landerman LR, Blazer DG, Saunders AM, Harris TB, Launer LJ. The relationship of APOE genotype to cognitive functioning in older African-American and Caucasian community residents. J Am Geriatr Soc. 2001;49(9):1148-1155.
8. Sawyer K, Sachs-Ericsson N, Preacher KJ, Blazer DG. Racial differences in the influence of the APOE epsilon 4 allele on cognitive decline in a sample of community-dwelling older adults. Gerontology. 2009;55(1):32-40.
9. Evans DA, Bennett DA, Wilson RS, et al. Incidence of Alzheimer disease in a biracial urban community: relation to apolipoprotein E allele status. Arch Neurol. 2003;60(2):185-189.
10. Tang MX, Stern Y, Marder K, et al. The APOE-ε4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics. JAMA. 1998;279(10):751-755.
11. Maestre G, Ottman R, Stern Y, et al. Apolipoprotein E and Alzheimer's disease: ethnic variation in genotypic risks. Ann Neurol. 1995;37(2):254-259.
12. Tang M-X, Maestre G, Tsai W-Y, et al. Relative risk of Alzheimer disease and age-at-onset distributions, based on APOE genotypes among elderly African Americans, Caucasians, and Hispanics in New York City. Am J Hum Genet. 1996;58(3):574-584.
13. Skoog I, Hesse C, Aevarsson O, et al. A population study of apoE genotype at the age of 85: relation to dementia, cerebrovascular disease, and mortality. J Neurol Neurosurg Psychiatry. 1998;64(1):37-43.
14. Corrada MM, Paganini-Hill A, Berlau DJ, Kawas CH. Apolipoprotein E genotype, dementia, and mortality in the oldest old: the 90+ Study. Alzheimers Dement. 2013;9(1):12-18.
15. Rentz DM, Locascio JJ, Becker JA, et al. Cognition, reserve, and amyloid deposition in normal aging. Ann Neurol. 2010;67(3):353-364.
16. Stern Y. Cognitive reserve in ageing and Alzheimer's disease. Lancet Neurol. 2012;11(11): 1006-1012.
17. Harris TB, Visser M, Everhart J, et al. Waist circumference and sagittal diameter reflect total body fat better than visceral fat in older men and women: the Health, Aging and Body Composition Study. Ann N Y Acad Sci. 2000;904(1):462-473.
18. Rooks RN, Simonsick EM, Miles T, et al. The association of race and socioeconomic status with cardiovascular disease indicators among older adults in the Health, Aging, and Body Composition Study. J Gerontol B Psychol Sci Soc Sci. 2002;57(4):S247-S256.
19. Yaffe K, Barnes D, Lindquist K, et al; Health ABC Investigators. Endogenous sex hormone levels and risk of cognitive decline in an older biracial cohort. Neurobiol Aging. 2007;28(2):171-178.
20. Teng EL, Chui HC. The Modified Mini-Mental State (3MS) Examination. J Clin Psychiatry. 1987;48(8):314-318.
21. McDowell I, Kristjansson B, Hill GB, Hébert R. Community screening for dementia: the Mini Mental State Exam (MMSE) and Modified Mini-Mental State Exam (3MS) compared. J Clin Epidemiol. 1997;50(4):377-383.
22. Davis TC, Long SW, Jackson RH, et al. Rapid Estimate of Adult Literacy in Medicine: a shortened screening instrument. Fam Med. 1993;25(6):391-395.
23. Yaffe K, Kanaya A, Lindquist K, et al. The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA. 2004;292(18):2237-2242.
24. Radloff LS. The CES-D Scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1(3):385-401.
25. Vogelzangs N, Beekman AT, Kritchevsky SB, et al. Psychosocial risk factors and themetabolic syndrome in elderly persons: findings from the Health, Aging and Body Composition study. J Gerontol A Biol Sci Med Sci. 2007;62(5):563-569.
26. Strobl C, Malley J, Tutz G. An introduction to recursive partitioning: rationale, application, and characteristics of classification and regression trees, bagging, and random forests. Psychol Methods. 2009;14(4):323-348.
27. R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing. 2013. http://www.R-project.org/. Accessed May 1, 2014.
28. Hothorn T, Bühlmann P, Dudoit S, Molinaro A, van der Laan MJ. Survival ensembles. Biostatistics. 2006;7(3):355-373.
29. Strobl C, Boulesteix A-L, Zeileis A, Hothorn T. Bias in random forest variable importance measures: illustrations, sources and a solution. BMC Bioinformatics. 2007;8(1):25. doi:10.1186/1471-2105-8-25.
30. Strobl C, Boulesteix A-L, Kneib T, Augustin T, Zeileis A. Conditional variable importance for random forests. BMC Bioinformatics. 2008;9(1):307. doi:10.1186/1471-2105-9-307.
31. Vemuri P, Lesnick TG, Przybelski SA, et al. Association of lifetime intellectual enrichment with cognitive decline in the older population. JAMA Neurol. 2014;71(8):1017-1024.
32. Sheffler J, Moxley J, Sachs-Ericsson N. Stress, race, and APOE: understanding the interplay of risk factors for changes in cognitive functioning. Aging Ment Health. 2014;18(6):784-791.
33. Lupien SJ, McEwen BS, Gunnar MR, Heim C. Effects of stress throughout the lifespan on the brain, behaviour and cognition. Nat Rev Neurosci. 2009;10(6):434-445.
34. Altmann A, Tian L, Henderson VW, Greicius MD; Alzheimer's Disease Neuroimaging Initiative Investigators. Sex modifies the APOE-related risk of developing Alzheimer disease. Ann Neurol. 2014;75(4):563-573.
35. Keage HAD, Banks S, Yang KL, Morgan K, Brayne C, Matthews FE. What sleep characteristics predict cognitive decline in the elderly? Sleep Med. 2012;13(7):886-892.
36. Benito-León J, Bermejo-Pareja F, Vega S, Louis ED. Total daily sleep duration and the risk of dementia: a prospective population-based study. Eur J Neurol. 2009;16(9):990-997.
37. Ferrari C, Xu W-L, Wang H-X, et al. How can elderly apolipoprotein E ε4 carriers remain free from dementia? Neurobiol Aging. 2013;34(1):13-21.
38. Sachs-Ericsson NJ, Sawyer KA, Corsentino EA, Collins NA, Blazer DG. APOE ε4 allele carriers: biological, psychological, and social variables associated with cognitive impairment. Aging Ment Health. 2010;14(6):679-691.